Introducing Menopause Hormone Therapy
Menopause hormone therapy (MHT) is a new term for what used to be called hormone replacement therapy or HRT. If you’ve never heard about menopause hormone therapy, it’s worth remembering that the change of name
Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993

For visual reference only; actual product may vary
US Name:
Tepezza
Alternative Names:
Tepezza
Active Ingredients:
Teprotumumab
Brand Manufacturer:
Manufacturer Location:
Click here to view Product Insert
Click here to view Product Insert
Click here to view Product Insert

For visual reference only; actual product may vary
Tepezza (Teprotumumab) is a targeted intravenous (IV) infusion for adults with Thyroid Eye Disease (TED). It works by blocking a key receptor to reduce eye bulging (proptosis), double vision, and swelling. This product requires special cold shipping.
| Tepezza Brand | 500mg 1 Vial |
-
|
Our price: $30,020.00 |
Tepezza is an intravenous prescription medication used to treat adults with Thyroid Eye Disease, also known as TED. The active ingredient is teprotumumab-trbw. TED is an autoimmune condition where the body’s immune system attacks the tissues behind the eyes. This causes inflammation, swelling, and scarring. The result is often eye bulging, double vision, and eye pain. Tepezza is a targeted therapy that treats the underlying cause of TED, not just the symptoms. It is the first and only FDA-approved prescription medicine for this condition.
Tepezza works by targeting and blocking a specific protein on the surface of your cells. This protein is called the insulin-like growth factor-1 receptor, or IGF-1R. In people with Thyroid Eye Disease, this receptor is overactive. It signals the tissues behind the eye to expand and become inflamed. By blocking the IGF-1R, Tepezza stops these signals. This calms the inflammation and reduces the growth of tissue. As a result, Tepezza can decrease eye bulging, improve double vision, and relieve pain and swelling associated with TED.
Tepezza is designed for adults diagnosed with moderate to severe Thyroid Eye Disease. This treatment may be right for you if you experience significant symptoms. These include eye bulging (proptosis), double vision (diplopia), or swelling that impacts your daily life. It is intended for patients seeking to treat the root cause of TED. Tepezza offers a non-surgical option for symptom relief. Your prescription must come from a qualified specialist, like an endocrinologist or ophthalmologist. This drug is not for women who are pregnant or planning to become pregnant.
Tepezza is administered by a healthcare professional as an intravenous (IV) infusion. You cannot take this medication at home. The complete course of treatment involves a total of eight infusions. An infusion is given once every three weeks. The first two infusions typically last around 90 minutes each. If these are well-tolerated, the remaining six infusions may be shortened to about 60 minutes. Your doctor calculates the specific dose based on your body weight. It is important to complete all eight infusions for the best results.
Tepezza may cause several side effects, although not everyone will experience them. The most common ones are muscle spasms or cramps, nausea, hair loss, and fatigue. Some people may also have diarrhea, high blood sugar, hearing problems, or changes in taste. Most side effects are mild to moderate. More serious side effects can occur. These include infusion reactions, worsening of inflammatory bowel disease (IBD), and high blood sugar. Always tell your doctor about any side effects you experience during treatment.
IsraelPharm provides a reliable and affordable source for brand-name medications like Tepezza. We connect you with licensed international pharmacies, offering significant savings on your prescriptions. Our experienced customer care team is available to guide you through the ordering process. We ensure that your medication is authentic and sourced from regulated suppliers. Enjoy the convenience of having your treatment delivered directly to you. We are committed to making essential medications more accessible and affordable without compromising on safety or quality. Choose IsraelPharm for a trusted healthcare partner.
Tepezza may cause side effects in some individuals. The most common ones include:
Though less common, seek medical attention if you experience:
Tepezza may begin to show effects within a few weeks of the first infusions. Many patients report noticeable improvements in eye bulging and double vision after the second or third infusion, which occurs around week six. The full benefits of the treatment are typically seen after completing the full course of eight infusions over about five months.
Tepezza is used to treat Thyroid Eye Disease, an autoimmune condition linked to Graves' disease. In TED, your immune system mistakenly attacks the muscle and fat tissue behind your eyes. This causes inflammation, leading to symptoms like eye bulging (proptosis), double vision, pain, and swelling. Tepezza targets the underlying cause of this process.
Tepezza is not a form of chemotherapy. It is a targeted therapy called a monoclonal antibody. Unlike chemotherapy, which affects many cell types, Tepezza is designed to specifically block the IGF-1R protein that is overactive in Thyroid Eye Disease. This helps reduce inflammation without the broad effects of a chemo drug.
Tepezza can increase blood sugar levels, which requires careful management for patients with diabetes or pre-diabetes. Your doctor will need to monitor your blood sugar closely before, during, and after your treatment course. Adjustments to your diabetes medication may be necessary to maintain safe glucose levels while you are receiving Tepezza infusions.
Tepezza works best when infusions are given on a consistent schedule of once every three weeks. If you miss a scheduled appointment, you should contact your healthcare provider as soon as possible. They will work with you to reschedule your infusion and adjust your treatment plan to ensure you get the best possible results from the therapy.
Tepezza may cause hair thinning or hair loss in some patients, but this side effect is typically temporary. In most cases, hair begins to grow back after the treatment course is completed. If you experience significant or concerning hair loss while taking Tepezza, discuss it with your doctor for management advice and reassurance.
Tepezza has been shown to provide long-lasting reduction in eye bulging and double vision for many patients with Thyroid Eye Disease. Clinical studies have shown that the improvements seen after a full treatment course are often sustained over time. However, individual results can vary, and you should discuss long-term expectations with your specialist.
Tepezza is not recommended for women who are pregnant or planning to become pregnant, as it may cause harm to a developing fetus. Women of childbearing potential should use effective contraception before starting, during, and for at least six months after the final dose of Tepezza. Discuss your family planning with your doctor before starting treatment.
Tepezza is a specialty medication that must be handled by a healthcare professional in a clinical setting. It requires refrigeration and careful preparation before being administered as an intravenous infusion. You will not need to worry about storing Tepezza at home, as it will be managed entirely by your infusion center or hospital.
Tepezza may cause infusion-related reactions, which are similar to an allergic response. Symptoms can include shortness of breath, a fast heartbeat, high blood pressure, and muscle pain. These reactions most often occur during the infusion itself. Your healthcare team will monitor you closely during each treatment to manage any potential reactions promptly and safely.
Tepezza may cause hearing-related side effects, including hearing loss or ringing in the ears (tinnitus). Your doctor might recommend a hearing test before you start treatment and monitor your hearing throughout. You should report any changes in your hearing to your doctor immediately, as they may need to adjust your treatment plan.
Tepezza can potentially cause or worsen inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. Patients with a history of IBD must inform their doctor before starting treatment. If you develop symptoms like ongoing diarrhea, abdominal pain, or blood in your stool during treatment, report them to your doctor right away.
Tepezza is a specialized treatment for Thyroid Eye Disease and is typically prescribed by an ophthalmologist (an eye specialist) or an endocrinologist (a hormone specialist). These doctors have the expertise to diagnose TED and determine if Tepezza is the appropriate course of treatment for your specific condition and symptoms.
Tepezza does not require extensive preparation on your part. Your healthcare provider will give you specific instructions, which may include drinking plenty of water and eating a normal meal before your appointment. You should also provide a full list of your current medications and health conditions to your doctor before your first infusion.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.
Menopause hormone therapy (MHT) is a new term for what used to be called hormone replacement therapy or HRT. If you’ve never heard about menopause hormone therapy, it’s worth remembering that the change of name

You’ve probably seen headlines questioning the safety of GLP-1 medicines – the cornerstone of the wave of the latest drugs that have revolutionized many areas of healthcare, primarily in control of type 2 diabetes and

People whose weight is higher than what is considered healthy for their height are described as having excessive body mass, clinically defined as being overweight or obese. Both of these can increase a person’s risk


